CASE REPORT
Published on 27 May 2025
Case Report: Robust and durable response to the combination of tislelizumab and chemotherapy in advanced thymic epithelial tumors: a case series
doi 10.3389/fimmu.2025.1516297
- 1,171 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Thymus Biology: Development, Immunodeficiency and Cancer Progression
Thymus Biology: Development, Immunodeficiency and Cancer Progression
2,182
Total downloads
10k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 11 Apr 2025
Multi-sequence MRI based radiomics nomogram for prediction expression of programmed death ligand 1 in thymic epithelial tumor
doi 10.3389/fimmu.2025.1555530
- 870 views
REVIEW
Published on 29 Aug 2024
Neuroendocrine neoplasms of the thymus
doi 10.3389/fimmu.2024.1465775
- 1,768 views
- 2 citations
ORIGINAL RESEARCH
Published on 12 Jul 2024
Recombinant FOXN1 fusion protein increases T cell generation in old mice
doi 10.3389/fimmu.2024.1423488
- 2,027 views
- 1 citation
CASE REPORT
Published on 03 Jul 2024
Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor
doi 10.3389/fimmu.2024.1423800
- 1,918 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
T Cell Biology
Immunological Tolerance and Regulation
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: